Integrative Research supports cancer researchers studying evidence-based complementary therapies alongside conventional treatment to manage symptoms and side effects and improve patients’ quality of life.
Medical Research Awards support early-career scientists studying leukemia, lymphoma, and related blood cancers to advance prevention, detection, and treatment, prioritizing work likely to reach clinical trials.
CRI Clinic and Laboratory Integration Program supports investigator teams translating cancer immunology discoveries into immune-based approaches to prevent initial cancer development and recurrence.
CRI Impact Grant supports researchers conducting clinically relevant chordoma research that bridges laboratory and clinical discovery to translate immunological findings into cancer immunotherapies.
CRI Clinical Innovator supports academic researchers leading early-phase cancer immunotherapy trials to test novel treatments, study response mechanisms, and identify biomarkers to improve patient outcomes.
Clinical Cancer Research supports investigators conducting patient-centered cancer trials and early-detection studies to improve treatment options, enable earlier intervention, and enhance quality of life.